mpss
massiv
parallel
signatur
sequenc
use
analyz
mirnom
three
mockinfect
three
prrsvinfect
lung
tissu
sampl
abund
valu
known
mirna
normal
use
transcript
per
million
tpm
small
rna
librari
result
show
normal
lung
tissu
mirna
poorli
express
tpm
mirna
modestli
express
tpm
mirna
show
moder
high
express
tpm
wherea
mirna
highli
express
tpm
infect
lung
tissu
mirna
poorli
express
tpm
mirna
modestli
express
tpm
mirna
show
moder
high
express
tpm
wherea
mirna
highli
express
tpm
total
seventytwo
express
mirna
tpm
chang
sever
select
mirna
tpm
fold
use
analysi
tabl
mirna
abundantli
express
mirnom
appear
import
interact
lung
prrsv
infect
mirna
tpm
alter
consid
like
import
prrsv
pathogenesi
studi
tabl
togeth
mirnom
mock
prrsvinfect
piglet
lung
enabl
identif
downregul
mirna
prrsvinfect
pam
cell
shown
fig
abund
mirna
prrsvinfect
cell
confirm
qrtpcr
express
consist
markedli
decreas
pam
cell
fig
cell
fig
compar
match
mock
control
uvprrsv
howev
chang
prrsv
infect
found
rel
small
infect
pam
fig
cell
fig
determin
whether
prrsv
infect
affect
express
level
pam
cell
quantifi
qpcr
differ
time
point
prrsv
infect
shown
fig
show
pronounc
progress
downregul
pam
cell
infect
prrsv
earli
h
post
infect
compar
mock
control
addit
prrsv
inactiv
uv
irradi
alter
express
indic
import
interact
cell
prrsv
infect
data
shown
panel
mirna
mimic
inhibitor
variou
mirna
includ
synthet
ascertain
impact
prrsv
replic
pam
cell
transfect
mimic
inhibitor
mirna
ng
follow
infect
prrsv
strain
moi
cell
collect
h
post
infect
determin
level
viral
propag
among
mirna
test
mimic
significantli
reduc
progeni
prrsv
product
determin
viral
titer
pfu
ml
fig
convers
transfect
inhibitor
counteract
effect
fig
indic
antivir
activ
prrsv
replic
microrna
mimicsinhibitor
test
studi
undetect
effect
progeni
viru
yield
pam
cell
fig
b
howev
could
exclud
possibl
undetect
effect
mirna
mimic
inhibitor
may
due
highlow
express
endogen
mirna
determin
whether
inhibit
prrsv
replic
pam
cell
transfect
mimic
inhibitor
ng
follow
infect
prrsv
strain
moi
cell
collect
h
post
infect
determin
viral
propag
shown
fig
viral
titer
mimictransfect
cell
markedli
progress
decreas
pam
cell
infect
prrsv
earli
h
h
post
infect
compar
match
inhibitortransfect
cell
determin
dose
effect
prrsv
replic
pam
cell
cell
transfect
increas
concentr
mimic
control
mimic
ng
follow
prrsv
infect
h
transfect
viral
plaqu
assay
demonstr
ectop
express
mimic
reduc
prrsv
replic
dosedepend
manner
pam
cell
compar
control
fig
consist
find
mimic
dosedepend
reduc
accumul
prrsv
cell
fig
exclud
possibl
inhibitor
effect
prrsv
replic
result
cellular
toxic
pam
cell
transfect
mimic
control
mimic
differ
dose
ng
appreci
effect
ng
cellular
viabil
morpholog
observ
data
shown
collect
data
unequivoc
confirm
inhibit
prrsv
replic
verifi
specif
target
prrsv
genom
cdna
fragment
repres
variou
code
region
prrsv
genom
amplifi
clone
report
vector
pmirreport
ambion
downstream
firefli
luciferas
gene
fig
result
indic
rel
luciferas
activ
differ
vector
contain
variou
prrsv
cdna
segment
h
post
transfect
differ
significantli
cell
transfect
mimic
compar
transfect
mimic
control
fig
thu
appear
directli
target
prrsv
genom
verifi
regul
proinflammatori
cytokin
prrsvinfect
pam
cell
mrna
level
mock
mirna
mimic
inhibitortransfect
control
mimic
inhibitortransfect
cell
evalu
h
post
infect
mrna
express
mimictransfect
cell
substanti
decreas
compar
control
mimic
fig
correspondingli
mrna
level
list
cytokin
differ
significantli
mirna
inhibitor
control
inhibitortransfect
cell
fig
similar
result
also
observ
cell
fig
taken
togeth
mimic
regul
express
proinflammatori
cytokin
thirteen
target
gene
role
prrsv
pathogenesi
predict
use
su
scrofa
unigen
databas
ncbi
miranda
algorithm
version
http
wwwmicrornaorg
tabl
mrna
contain
site
fig
use
report
gene
system
verifi
databas
predict
result
indic
mimic
synthet
mirna
mimic
function
endogen
significantli
inhibit
luciferas
activ
report
affect
luciferas
activ
possibl
target
gene
report
mutat
site
fig
although
abl
significantli
suppress
luciferas
activ
addit
ng
inhibitor
ad
ng
inhibitor
revers
suppress
trend
fig
indic
endogen
target
regul
identifi
role
prrsv
pathogenesi
gene
subject
enrich
analysi
cell
signal
pathway
use
kyoto
encyclopedia
gene
genom
kegg
pathway
databas
http
wwwgenomejpkegg
analysi
result
indic
nuclear
factor
signal
pathway
enrich
predict
target
activ
known
play
critic
role
prrsv
hypothesi
signal
pathway
involv
antivir
effect
target
verifi
result
show
sirna
downregul
express
myeloid
differenti
primari
respons
gene
inhibit
activ
cell
fig
moreov
inhibit
pcdna
also
enhanc
activ
pathway
cell
fig
indic
inhibit
signal
pathway
suppress
prrsv
pathogenesi
fig
antivir
effect
test
prrsvinfect
spf
piglet
fourweekold
femal
spf
piglet
intraven
administ
synthet
mimic
nmol
per
day
one
day
inocul
prrsv
strain
piglet
control
mimicinfect
group
show
sever
clinic
symptom
h
post
infect
piglet
start
develop
elev
bodi
temperatur
peak
h
post
infect
peak
h
post
infect
observ
piglet
mirna
mimicinfect
group
fig
bodi
weight
gain
piglet
control
mimicinfect
group
reduc
compar
mock
mirna
mimicinfect
group
fig
lung
wet
dri
weight
ratio
control
mimicinfect
piglet
higher
mirnainfect
pig
signific
differ
h
post
infect
p
fig
histopatholog
chang
lung
infect
piglet
observ
h
follow
inocul
shown
fig
infiltr
predominantli
inflammatori
cell
interstiti
pneumonia
sever
hyperemia
observ
lung
control
mimicinfect
pig
h
post
infect
fig
howev
mirna
mimicinfect
group
obviou
hyperemia
lung
observ
h
post
infect
fig
light
hyperemia
h
post
infect
observ
fig
obviou
histopatholog
chang
observ
noninfect
group
fig
addit
prrsv
detect
sera
control
mimicinfect
pig
day
post
infect
observ
mirna
mimicinfect
pig
day
post
infect
rtpcr
data
shown
viral
titer
lung
control
mimic
mirnainfect
pig
calcul
h
post
infect
respect
data
shown
taken
togeth
result
indic
mimic
signific
inhibitori
effect
viral
replic
prrsvinocul
spf
piglet
mirna
function
mainli
repress
express
cellular
mirna
may
regul
viral
replic
target
sequenc
viral
andor
regul
cellular
pathway
involv
viral
life
abundantli
express
mirna
appear
import
express
rel
low
level
studi
result
indic
mirna
abundantli
differ
express
lung
tissu
infect
control
pig
howev
account
larg
part
mirnom
data
studi
demonstr
novel
antivir
host
factor
prrsv
reduc
product
prrsv
progeni
contrast
inhibit
substanti
enhanc
prrsv
propag
cell
pam
main
target
cell
type
prrsv
replic
vivo
confirm
biolog
relev
find
target
host
factor
develop
antivir
drug
advantag
higher
genet
barrier
emerg
viral
escap
mutant
identif
character
inhibitor
prrsv
replic
may
suggest
new
option
control
futur
prr
outbreak
current
control
measur
remain
inadequ
present
studi
reduct
prrsv
replic
appear
involv
direct
target
prrsv
genom
howev
data
indic
might
act
provir
cellular
factor
pathway
reduc
prrsv
replic
although
long
consid
key
transcript
factor
express
varieti
antivir
pathogen
redirect
activ
virussupport
exampl
influenza
virus
replic
higher
titer
cell
preactiv
convers
progeni
viru
product
reduc
signal
william
et
al
report
sustain
induct
requir
effici
express
latent
hiv
type
show
studi
optim
replic
prrsv
viru
arterivirida
famili
also
reli
data
interact
prrsv
pathway
also
somewhat
controversi
lee
et
first
demonstr
prrsv
infect
activ
signal
cell
pam
via
ikb
degrad
nuclear
transloc
previou
studi
also
show
prrsv
infect
trigger
nucleocapsid
n
protein
prrsv
could
activ
ectop
express
howev
activ
could
detect
h
post
infect
contrast
ectop
express
sever
individu
prrsv
nsp
protein
report
neg
regul
activ
exampl
sun
et
al
report
prrsv
inhibit
signal
pathway
interf
polyubiquitin
process
furthermor
prrsv
could
inhibit
activ
suppress
taken
togeth
reason
conclud
prrsv
activ
late
phase
infect
prrsv
may
develop
sophist
strategi
either
activ
inhibit
benefit
differ
stage
life
cycl
elabor
mechan
prrsv
regul
activ
latter
promot
prrsv
replic
requir
studi
show
decreas
follow
infect
pam
cell
present
studi
compar
basal
express
level
pam
qpcr
found
among
highli
express
mirna
examin
data
shown
interestingli
found
prrsv
infect
downregul
express
infect
progress
signific
downregul
first
observ
h
reduct
level
observ
later
time
point
plausibl
specul
prrsv
infect
gradual
decreas
mrna
express
turn
reliev
stabil
effect
mrna
ultim
lead
subsequ
activ
studi
significantli
inhibit
level
proinflammatori
cytokin
timedepend
manner
cell
furthermor
explor
effect
prrsv
infect
spf
piglet
evalu
bodi
temperatur
bodi
weight
viral
titer
patholog
chang
among
other
although
signific
differ
lung
patholog
chang
mirna
mimicinfect
group
control
mimicinfect
group
h
post
infect
result
show
treatment
mimic
significantli
reduc
damag
infect
piglet
earli
stage
addit
previou
studi
show
tolllik
receptor
tlr
signal
cascad
may
involv
prrsvinduc
summari
data
demonstr
antivir
host
factor
restrict
prrsv
replic
instead
directli
target
prrsv
genom
exert
antivir
effect
neg
regul
cellular
signal
shown
provir
factor
prrsv
replic
surviv
strategi
prrsv
downregul
express
post
infect
activ
facilit
replic
highli
pathogen
prrsv
strain
use
throughout
present
viral
strain
passag
five
time
cell
cell
line
purchas
american
type
cultur
collect
atcc
cultur
dmem
invitrogen
supplement
fetal
bovin
serum
fb
uml
penicillin
mgml
streptomycin
humidifi
incub
porcin
alveolar
macrophag
pam
obtain
lung
lavag
specif
pathogenfre
piglet
previous
pam
batch
test
suscept
prrsv
infect
highli
prrsvsuscept
cell
use
present
studi
prior
use
pam
suspend
cellsml
emem
fc
infect
assay
pam
nonadher
state
use
total
cell
suspens
ad
steril
ml
eppendorf
polypropylen
tube
tube
cap
pierc
g
needl
allow
air
exchang
cultur
incub
humidifi
air
atmospher
lung
tissu
sampl
obtain
mockinfect
prr
virusinfect
pig
h
post
infect
immedi
snapfrozen
liquid
nitrogen
store
use
brief
specificpathogenfre
spf
larg
white
duroc
crossbr
wean
piglet
n
obtain
swine
herd
beij
center
spf
swine
breed
manag
piglet
randomli
assign
two
group
prr
viru
infect
group
n
mockinfect
control
group
n
piglet
prrsvinfect
group
asept
inocul
intranas
ml
intramuscularli
ml
prrsv
inocul
piglet
monitor
clinic
sign
infect
describ
food
water
avail
ad
libitum
piglet
human
sacrif
necessari
amelior
suffer
experi
perform
accord
nation
institut
health
guid
care
use
laboratori
anim
nih
public
approv
anim
care
use
committe
institut
zoolog
chines
academi
scienc
effort
made
minim
suffer
reduc
number
anim
use
total
rna
virusinfect
group
n
mockinfect
group
n
extract
use
mirneasi
mini
kit
qiagen
germani
accord
manufactur
protocol
rna
qualiti
quantiti
solexa
sequenc
evalu
use
agil
bioanalyz
sequenc
perform
accord
chen
et
sequenc
data
analyz
use
soap
short
oligonucleotid
align
program
follow
li
et
clean
sequenc
read
exclud
read
contain
ambigu
base
adaptor
contamin
yield
solexa
sequenc
use
analysi
remov
read
classifi
small
rna
rrna
speci
rrna
trna
scrna
snrna
snorna
length
distribut
mirnamapp
data
read
famili
annot
calcul
data
shown
sequenc
sequenc
process
use
illumina
genom
analyz
pipelin
softwar
subject
seri
data
filtrat
step
use
mammalian
mirna
data
mirbbas
obtain
mappabl
sequenc
program
merg
refer
databas
pig
genom
bbp
ftp
ftpsangeracukpubsscrofaassembl
nonredund
est
billion
nt
ftp
ftpncbinihgovrepositorydbest
construct
avail
complet
sequenc
databas
pig
name
pig
genom
est
use
map
antibodi
specif
tolllik
receptor
cell
signal
technolog
danver
antibodi
specif
horseradish
peroxidasecoupl
secondari
antibodi
obtain
describ
cholesterolconjug
mimic
sirna
vivo
rna
deliveri
mimic
inhibitor
vitro
transfect
respect
neg
control
ribobio
co
guangzhou
china
mirna
express
pam
mock
viralinfect
lung
tissu
assay
h
post
infect
total
rna
extract
pam
trizol
reagent
purifi
accord
manufactur
recommend
invitrogen
use
mirna
express
assay
correspondingli
mirna
express
evalu
mock
virusinfect
cell
time
point
addit
mrna
level
proinflammatori
cytokin
pam
cell
lung
tissu
measur
differ
time
point
cellular
gadph
mrna
rna
extract
use
intern
control
total
rna
convert
cdna
use
random
primer
reaction
amplifi
use
sybr
green
master
mix
follow
manufactur
protocol
vazym
china
primer
sequenc
mirna
target
cytokin
well
gadph
list
support
materi
tabl
potenti
target
gene
select
signific
differenti
express
mirna
identifi
use
su
scrofa
unigen
databas
ncbi
miranda
algorithm
version
http
wwwmicrornaorg
follow
paramet
set
score
threshold
free
energi
threshold
kcalmol
list
potenti
target
gene
filter
use
follow
higher
stringenc
method
match
nucleotid
mirna
target
sequenc
match
nucleotid
mirna
target
sequenc
g
u
wobbl
toler
mirna
bind
site
must
lie
within
potenti
target
gene
flank
mirna
bind
site
pcramplifi
pig
genom
dna
use
genespecif
primer
tabl
pcr
product
target
gene
subclon
pmirreport
vector
downstream
luciferas
orf
gener
report
vector
pmirnfyb
pmirepcam
pmirmmd
cdna
construct
verifi
dna
sequenc
determin
whether
target
viral
segment
pmirreport
luciferas
report
vector
ambion
use
clone
vector
report
gene
assay
analyz
potenti
target
region
prrsv
genom
accord
method
report
cdna
fragment
correspond
nonstructur
structur
gene
prrsv
amplifi
pcr
prrsv
rna
strain
subclon
pmirreport
vector
downstream
luciferas
orf
gener
report
vector
respect
primer
use
list
tabl
cdna
construct
verifi
dna
sequenc
cell
seed
plate
incub
overnight
indic
plasmid
mirna
mimic
inhibitor
transfect
cell
use
lipofectamin
invitrogen
carlsbad
ca
accord
manufactur
protocol
briefli
h
transfect
firefli
renilla
luciferas
activ
measur
use
dualluciferas
assay
kit
promega
plate
reader
perkinelm
usa
renilla
firefli
luciferas
signal
detect
use
verita
micropl
luminomet
turner
biosystem
sunnyval
ca
usa
firefli
luciferas
signal
normal
renilla
luciferas
signal
normal
firefli
luciferas
activ
compar
mimic
control
mimic
cell
result
express
rel
activ
target
construct
test
triplic
assay
repeat
confirm
result
cell
transfect
mimic
control
mimic
inhibitor
sirna
prior
prrsv
infect
lp
cell
collect
day
post
infect
lyse
ad
lysi
buffer
lba
mm
trishcl
ph
sodium
dodecyl
sulfat
dldithiothreitol
glycerol
cell
lysat
analyz
express
western
blot
use
specif
monoclon
antibodi
mab
primari
antibodi
detect
monoclon
antibodi
mab
beyotim
china
normal
protein
content
sampl
mimic
control
mimic
transfect
cell
use
lipofectamin
invitrogen
accord
manufactur
instruct
treat
cell
infect
prrsv
viru
multipl
infect
moi
one
hour
incub
cell
wash
warm
pb
incub
dmem
medium
supplement
uml
penicillin
streptomycin
tpcktreat
trypsin
bovin
serum
albumin
fraction
v
supernat
collect
h
store
assay
determin
whether
viru
replic
dosedepend
manner
cell
pam
cell
transfect
mimic
control
mimic
indic
dose
ng
follow
prrsv
infect
moi
studi
antivir
effect
piglet
group
piglet
intraven
inject
volum
pb
control
group
noninfect
synthet
nmol
control
mimic
nmol
per
day
day
day
piglet
inocul
intranas
highli
pathogen
prrsv
strain
strain
ml
dose
piglet
mimictr
group
eighteen
pig
n
time
point
slaughter
h
post
infect
two
portion
lobe
left
lung
collect
immedi
fix
paraformaldehyd
solut
whole
left
lung
weigh
desicc
dri
constant
weight
lung
wet
dri
weight
ratio
determin
use
one
indic
lung
lung
histopatholog
chang
h
post
infect
analyz
base
previous
describ
accord
method
reedmuench
viru
titrat
lung
determin
modif
briefli
lung
tissu
sampl
frozen
liquid
nitrogen
ground
fine
powder
use
mortar
pestl
weight
one
milligram
homogen
ml
cold
phosphatebuff
salin
clarifi
homogen
titrat
viral
infect
cell
cultur
plate
initi
dilut
viral
titer
express
mean
remain
piglet
n
monitor
day
viru
detect
serum
data
extract
independ
experi
express
mean
standard
deviat
statist
relationship
assess
use
student
test
consid
p
valu
signific
cite
articl
wang
c
et
al
identif
mirnom
reveal
potenti
therapeut
target
prr
viral
infect
sci
rep
doi
